Literature DB >> 23876253

Lipopolysaccharide-induced blood brain barrier permeability is enhanced by alpha-synuclein expression.

Adam Jangula1, Eric J Murphy.   

Abstract

Because α-synuclein (Snca) is involved in neuroinflammatory response, we determined if its expression altered blood-brain barrier (BBB) permeability. To induce increased BBB permeability, Snca gene-ablated (KO) and wild-type (WT) mice were injected (i.p.) with lipopolysaccharide (LPS). To assess changes in BBB permeability, Evans blue was injected (i.p.) and extravasation into the brain assessed using fluorescence spectroscopy. WT mice had a significant increase in BBB permeability at 1, 3, and 6h post-injection of LPS relative to untreated mice. Contrary to WT mice, LPS did not induce a time-dependent change in BBB permeability in KO mice. Although brain edema is associated with increased BBB permeability, no significant difference in edema was found between groups. These results show that Snca expression is associated with increased reactive opening of the BBB in response to LPS.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Blood–brain barrier; Edema; Lipopolysaccharide; Snca; α-Synuclein

Mesh:

Substances:

Year:  2013        PMID: 23876253      PMCID: PMC3799901          DOI: 10.1016/j.neulet.2013.06.058

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  57 in total

1.  Effect of LPS on the permeability of the blood-brain barrier to insulin.

Authors:  H Xaio; W A Banks; M L Niehoff; J E Morley
Journal:  Brain Res       Date:  2001-03-30       Impact factor: 3.252

2.  Rapid loss of microvascular integrin expression during focal brain ischemia reflects neuron injury.

Authors:  M Tagaya; H P Haring; I Stuiver; S Wagner; T Abumiya; J Lucero; P Lee; B R Copeland; D Seiffert; G J del Zoppo
Journal:  J Cereb Blood Flow Metab       Date:  2001-07       Impact factor: 6.200

3.  ApoE deficiency compromises the blood brain barrier especially after injury.

Authors:  N Methia; P André; A Hafezi-Moghadam; M Economopoulos; K L Thomas; D D Wagner
Journal:  Mol Med       Date:  2001-12       Impact factor: 6.354

4.  alpha-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins.

Authors:  R Sharon; M S Goldberg; I Bar-Josef; R A Betensky; J Shen; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

5.  Attenuation of brain edema, blood-brain barrier breakdown, and injury volume by ifenprodil, a polyamine-site N-methyl-D-aspartate receptor antagonist, after experimental traumatic brain injury in rats.

Authors:  R J Dempsey; M K Başkaya; A Doğan
Journal:  Neurosurgery       Date:  2000-08       Impact factor: 4.654

6.  A role for alpha-synuclein in the regulation of dopamine biosynthesis.

Authors:  Ruth G Perez; Jack C Waymire; Eva Lin; Jen J Liu; Fengli Guo; Michael J Zigmond
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

Review 7.  Inflammatory mediators and modulation of blood-brain barrier permeability.

Authors:  N J Abbott
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

8.  Different serotypes of endotoxin (lipopolysaccharide) cause different increases in albumin extravasation in rats.

Authors:  Torbjørn Nedrebø; Rolf K Reed
Journal:  Shock       Date:  2002-08       Impact factor: 3.454

9.  Demonstration of alpha-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment.

Authors:  Fumiaki Mori; Kunikazu Tanji; Makoto Yoshimoto; Hitoshi Takahashi; Koichi Wakabayashi
Journal:  Exp Neurol       Date:  2002-07       Impact factor: 5.330

10.  Expression of mutant alpha-synuclein modulates microglial phenotype in vitro.

Authors:  Lalida Rojanathammanee; Eric J Murphy; Colin K Combs
Journal:  J Neuroinflammation       Date:  2011-05-09       Impact factor: 8.322

View more
  22 in total

1.  Systemic lipopolysaccharide compromises the blood-labyrinth barrier and increases entry of serum fluorescein into the perilymph.

Authors:  Keiko Hirose; Jared J Hartsock; Shane Johnson; Peter Santi; Alec N Salt
Journal:  J Assoc Res Otolaryngol       Date:  2014-06-21

2.  Systemic lipopolysaccharide induces cochlear inflammation and exacerbates the synergistic ototoxicity of kanamycin and furosemide.

Authors:  Keiko Hirose; Song-Zhe Li; Kevin K Ohlemiller; Richard M Ransohoff
Journal:  J Assoc Res Otolaryngol       Date:  2014-05-21

3.  Endothelial JAM-A promotes reovirus viremia and bloodstream dissemination.

Authors:  Caroline M Lai; Karl W Boehme; Andrea J Pruijssers; Vrajesh V Parekh; Luc Van Kaer; Charles A Parkos; Terence S Dermody
Journal:  J Infect Dis       Date:  2014-08-22       Impact factor: 5.226

Review 4.  Parkinson's Disease: A Multisystem Disorder.

Authors:  Helena Nunes Costa; Ana Raquel Esteves; Nuno Empadinhas; Sandra Morais Cardoso
Journal:  Neurosci Bull       Date:  2022-08-22       Impact factor: 5.271

Review 5.  Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.

Authors:  Jinbing Xie; Zheyu Shen; Yasutaka Anraku; Kazunori Kataoka; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2019-09-14       Impact factor: 12.479

6.  LPS Induces Occludin Dysregulation in Cerebral Microvascular Endothelial Cells via MAPK Signaling and Augmenting MMP-2 Levels.

Authors:  Lan-hui Qin; Wen Huang; Xue-an Mo; Yan-lan Chen; Xiang-hong Wu
Journal:  Oxid Med Cell Longev       Date:  2015-07-28       Impact factor: 6.543

Review 7.  Astrocytic modulation of blood brain barrier: perspectives on Parkinson's disease.

Authors:  Ricardo Cabezas; Marcos Avila; Janneth Gonzalez; Ramon Santos El-Bachá; Eliana Báez; Luis Miguel García-Segura; Juan Camilo Jurado Coronel; Francisco Capani; Gloria Patricia Cardona-Gomez; George E Barreto
Journal:  Front Cell Neurosci       Date:  2014-08-04       Impact factor: 5.505

Review 8.  Overnutrition Determines LPS Regulation of Mycotoxin Induced Neurotoxicity in Neurodegenerative Diseases.

Authors:  Ian James Martins
Journal:  Int J Mol Sci       Date:  2015-12-10       Impact factor: 5.923

9.  Hypothalamic TLR2 triggers sickness behavior via a microglia-neuronal axis.

Authors:  Sungho Jin; Jae Geun Kim; Jeong Woo Park; Marco Koch; Tamas L Horvath; Byung Ju Lee
Journal:  Sci Rep       Date:  2016-07-12       Impact factor: 4.379

Review 10.  Potential of Neural Stem Cell-Based Therapy for Parkinson's Disease.

Authors:  Chung-Hsing Chou; Hueng-Chuen Fan; Dueng-Yuan Hueng
Journal:  Parkinsons Dis       Date:  2015-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.